A team of highly published, ICU critical care physician/scholors have conducted a comprehensive analysis of the rapidly accumulating scientific study data from the centers around the world supporting the efficacy of a repurposed oral medication. The team will announce the results of its research that demonstrates the consistent, reproducible, and high effectiveness of this safe, inexpensive, and globally available oral agent in both the prevention and treatment of COVID-19.
FLCCC ALLIANCE NEWS CONFERENCEDecember 4, 10:30 am (CST) at United Memorial Medical Center in Houston, Texas
The FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.
The FLCCC believes that their Critical Care team’s testimony will help to immediately alter the trajectory of this pandemic. Take a closer look at the data and publish their findings, or those of now dozens of studies (and more to come) on the efficacy of #ivermectin in the prophylaxis and treatment of #COVID-19. The FLCCC Urges policymakers to take action.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).